Delhivery Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 6, 2025, 12:24 am

Quick Insight

Delhivery Ltd's current market cap stands at a substantial 35,731 Cr., with a high P/E ratio of 180 indicating rich valuation. Despite a low ROE of 1.52% and ROCE of 2.47%, the company maintains a decent OPM of 6%, reflecting operational efficiency. The firm's strong Net Profit of 162 Cr. is supported by healthy reserves of 9,358 Cr., although it carries significant borrowings of ₹1,422 Cr. With a CCC of 58 days, Delhivery exhibits efficient working capital management. The P/BV ratio of 2.02x suggests a premium over book value, while an ICR of 6.49x indicates comfortable debt-servicing ability. Overall, investors should closely monitor Delhivery's ability to improve profitability and manage its debt levels effectively to ensure sustainable growth in the long term.

Competitors of Delhivery Ltd

All Competitor Stocks of Delhivery Ltd

Quarterly Result

Last Updated: August 19, 2025, 8:15 pm

Below is a detailed analysis of the quarterly data for Delhivery Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 2,294.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,192.00 Cr. (Mar 2025) to 2,294.00 Cr., marking an increase of 102.00 Cr..
• For Expenses, as of Jun 2025, the value is 2,153.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,072.00 Cr. (Mar 2025) to 2,153.00 Cr., marking an increase of 81.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 141.00 Cr.. The value appears strong and on an upward trend. It has increased from 119.00 Cr. (Mar 2025) to 141.00 Cr., marking an increase of 22.00 Cr..
• For OPM %, as of Jun 2025, the value is 6.00%. The value appears strong and on an upward trend. It has increased from 5.00% (Mar 2025) to 6.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 130.00 Cr.. The value appears strong and on an upward trend. It has increased from 129.00 Cr. (Mar 2025) to 130.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 34.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 34.00 Cr..
• For Depreciation, as of Jun 2025, the value is 147.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 142.00 Cr. (Mar 2025) to 147.00 Cr., marking an increase of 5.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 90.00 Cr.. The value appears strong and on an upward trend. It has increased from 72.00 Cr. (Mar 2025) to 90.00 Cr., marking an increase of 18.00 Cr..
• For Tax %, as of Jun 2025, the value is -2.00%. The value appears to be improving (decreasing) as expected. It has decreased from -1.00% (Mar 2025) to -2.00%, marking a decrease of 1.00%.
• For Net Profit, as of Jun 2025, the value is 91.00 Cr.. The value appears strong and on an upward trend. It has increased from 73.00 Cr. (Mar 2025) to 91.00 Cr., marking an increase of 18.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.22. The value appears strong and on an upward trend. It has increased from 0.97 (Mar 2025) to 1.22, marking an increase of 0.25.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:55 pm

Growth

Last Updated: September 5, 2025, 3:11 pm

Balance Sheet

Last Updated: July 25, 2025, 1:27 pm

Below is a detailed analysis of the balance sheet data for Delhivery Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 75.00 Cr.. The value appears strong and on an upward trend. It has increased from 74.00 Cr. (Mar 2024) to 75.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 9,358.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,071.00 Cr. (Mar 2024) to 9,358.00 Cr., marking an increase of 287.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,422.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,169.00 Cr. (Mar 2024) to 1,422.00 Cr., marking an increase of 253.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,209.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,139.00 Cr. (Mar 2024) to 1,209.00 Cr., marking an increase of 70.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 12,063.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11,453.00 Cr. (Mar 2024) to 12,063.00 Cr., marking an increase of 610.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 3,887.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,354.00 Cr. (Mar 2024) to 3,887.00 Cr., marking an increase of 533.00 Cr..
• For CWIP, as of Mar 2025, the value is 33.00 Cr.. The value appears strong and on an upward trend. It has increased from 29.00 Cr. (Mar 2024) to 33.00 Cr., marking an increase of 4.00 Cr..
• For Investments, as of Mar 2025, the value is 3,578.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,776.00 Cr. (Mar 2024) to 3,578.00 Cr., marking an increase of 802.00 Cr..
• For Other Assets, as of Mar 2025, the value is 4,565.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,295.00 Cr. (Mar 2024) to 4,565.00 Cr., marking a decrease of 730.00 Cr..
• For Total Assets, as of Mar 2025, the value is 12,063.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,453.00 Cr. (Mar 2024) to 12,063.00 Cr., marking an increase of 610.00 Cr..

Notably, the Reserves (9,358.00 Cr.) exceed the Borrowings (1,422.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

No data available for the No. of Shareholders chart.

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Delhivery Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 2.19. This value is below the healthy minimum of 5. It has increased from -3.40 (Mar 24) to 2.19, marking an increase of 5.59.
• For Diluted EPS (Rs.), as of Mar 25, the value is 2.14. This value is below the healthy minimum of 5. It has increased from -3.40 (Mar 24) to 2.14, marking an increase of 5.54.
• For Cash EPS (Rs.), as of Mar 25, the value is 9.25. This value is within the healthy range. It has increased from 6.29 (Mar 24) to 9.25, marking an increase of 2.96.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 126.51. It has increased from 124.11 (Mar 24) to 126.51, marking an increase of 2.40.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 126.51. It has increased from 124.11 (Mar 24) to 126.51, marking an increase of 2.40.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 119.80. It has increased from 110.50 (Mar 24) to 119.80, marking an increase of 9.30.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 10.94. This value is within the healthy range. It has increased from 7.86 (Mar 24) to 10.94, marking an increase of 3.08.
• For PBIT / Share (Rs.), as of Mar 25, the value is 3.77. This value is within the healthy range. It has increased from -1.93 (Mar 24) to 3.77, marking an increase of 5.70.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.01. This value is within the healthy range. It has increased from -3.44 (Mar 24) to 2.01, marking an increase of 5.45.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 2.08. This value is within the healthy range. It has increased from -3.50 (Mar 24) to 2.08, marking an increase of 5.58.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.17. This value is within the healthy range. It has increased from -3.38 (Mar 24) to 2.17, marking an increase of 5.55.
• For PBDIT Margin (%), as of Mar 25, the value is 9.13. This value is below the healthy minimum of 10. It has increased from 7.11 (Mar 24) to 9.13, marking an increase of 2.02.
• For PBIT Margin (%), as of Mar 25, the value is 3.14. This value is below the healthy minimum of 10. It has increased from -1.74 (Mar 24) to 3.14, marking an increase of 4.88.
• For PBT Margin (%), as of Mar 25, the value is 1.68. This value is below the healthy minimum of 10. It has increased from -3.10 (Mar 24) to 1.68, marking an increase of 4.78.
• For Net Profit Margin (%), as of Mar 25, the value is 1.73. This value is below the healthy minimum of 5. It has increased from -3.16 (Mar 24) to 1.73, marking an increase of 4.89.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.81. This value is below the healthy minimum of 8. It has increased from -3.06 (Mar 24) to 1.81, marking an increase of 4.87.
• For Return on Networth / Equity (%), as of Mar 25, the value is 1.71. This value is below the healthy minimum of 15. It has increased from -2.72 (Mar 24) to 1.71, marking an increase of 4.43.
• For Return on Capital Employeed (%), as of Mar 25, the value is 2.63. This value is below the healthy minimum of 10. It has increased from -1.40 (Mar 24) to 2.63, marking an increase of 4.03.
• For Return On Assets (%), as of Mar 25, the value is 1.34. This value is below the healthy minimum of 5. It has increased from -2.17 (Mar 24) to 1.34, marking an increase of 3.51.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.75. It has increased from 0.71 (Mar 24) to 0.75, marking an increase of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 4.23. This value exceeds the healthy maximum of 3. It has decreased from 4.42 (Mar 24) to 4.23, marking a decrease of 0.19.
• For Quick Ratio (X), as of Mar 25, the value is 4.22. This value exceeds the healthy maximum of 2. It has decreased from 4.41 (Mar 24) to 4.22, marking a decrease of 0.19.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 6.49. This value is within the healthy range. It has decreased from 6.54 (Mar 24) to 6.49, marking a decrease of 0.05.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.27. This value is below the healthy minimum of 3. It has increased from -1.66 (Mar 24) to 2.27, marking an increase of 3.93.
• For Enterprise Value (Cr.), as of Mar 25, the value is 18,723.45. It has decreased from 32,539.01 (Mar 24) to 18,723.45, marking a decrease of 13,815.56.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.10. This value is within the healthy range. It has decreased from 4.00 (Mar 24) to 2.10, marking a decrease of 1.90.
• For EV / EBITDA (X), as of Mar 25, the value is 22.95. This value exceeds the healthy maximum of 15. It has decreased from 56.17 (Mar 24) to 22.95, marking a decrease of 33.22.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.13. This value is within the healthy range. It has decreased from 4.03 (Mar 24) to 2.13, marking a decrease of 1.90.
• For Price / BV (X), as of Mar 25, the value is 2.02. This value is within the healthy range. It has decreased from 3.59 (Mar 24) to 2.02, marking a decrease of 1.57.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.13. This value is within the healthy range. It has decreased from 4.03 (Mar 24) to 2.13, marking a decrease of 1.90.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.01, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness